Related Experiment Video

Updated: Feb 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.3K

[Gene Analysis for the Sudden Death of Hypertrophic Cardiomyopathy by Whole Exome Sequencing.]

C C Xu1,2, Y Z Bai3, X S Xu4

  • 1Guangdong Medical University, Dongguan 523808, China.

Fa Yi Xue Za Zhi
|December 9, 2017
PubMed

Insights

Whole exome sequencing identified a MYBPC3 gene mutation (C719R) in a sudden hypertrophic cardiomyopathy death case. This molecular analysis offers insights into HCM causes and death investigations.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death.
  • Identifying genetic mutations is crucial for understanding HCM pathogenesis.

Purpose of the Study:

  • To perform whole exome sequencing on a sudden death case with HCM.
  • To identify pathogenic gene mutations related to the hypertrophic cardiomyopathy death.

Main Methods:

  • Whole exome sequencing (WES) was conducted on a hypertrophic cardiomyopathy (HCM) sudden death case.
  • Bioinformatic analysis, including variant screening and functional prediction, was performed using established software.

Main Results:

  • A heterozygous mutation, C719R, was identified in the MYBPC3 gene.
  • This mutation is associated with the pathological features of HCM in the deceased.

Conclusions:

  • Whole exome sequencing is effective for elucidating the molecular mechanisms of HCM.
  • This approach provides a novel method for investigating the causes of sudden cardiac death.
Abstract

Keywords:
cardiomyopathy, hypertrophicdeath, sudden, cardiacexomeforensic pathologymutation

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.4K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.1K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.8K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
605